Becton Dickinson (XSWX:BDX) Other Current Payables: CHF0 Mil (As of Mar. 2026)


XSWX:BDX Becton Dickinson & Co XSWX:BDX
70 GF Score
Price CHF125.66
GF Value CHF151.22
! 3 Warning Signs
View Full Analysis

What is Becton Dickinson Other Current Payables?

Becton Dickinson XSWX:BDX +0.45% 70 Other Current Payables is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:BDX with a GF Score™ of 70/100 and a GF Value™ of CHF151.22. The stock has 3 warning signs investors should review.

Becton Dickinson's Other Current Payables for the quarter that ended in Mar. 2026 was CHF0 Mil.

Becton Dickinson's annual Other Current Payables increased from Sep. 2023 (CHF0 Mil) to Sep. 2024 (CHF0 Mil) but then declined from Sep. 2024 (CHF0 Mil) to Sep. 2025 (CHF0 Mil).

Becton Dickinson Other Current Payables Related Terms

Becton Dickinson Other Current Payables Historical Data

* Premium members only.

The historical data trend for Becton Dickinson's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Becton Dickinson Other Current Payables Chart

Becton Dickinson Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Becton Dickinson Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:BDX
70GF Score
Becton Dickinson & Co XSWX:BDX
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Becton Dickinson Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of CHF0 Mil mean?
Becton Dickinson (XSWX:BDX) has a Other Current Payables of CHF0 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Becton Dickinson and its competitors.
Is Becton Dickinson's Other Current Payables too high?
Becton Dickinson's current Other Current Payables is CHF0 Mil. Overall, Becton Dickinson has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Becton Dickinson's Other Current Payables compare to MDLN and RMD?
Becton Dickinson's Other Current Payables of CHF0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Becton Dickinson and its competitors. Becton Dickinson's current Other Current Payables is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Becton Dickinson stock overvalued right now?
Becton Dickinson (XSWX:BDX) has a current Other Current Payables of CHF0 Mil. The stock's GF Value™ is CHF151.22, compared to a current price of CHF125.66 — trading 16.9% below its estimated fair value. The current Other Current Payables is CHF0 Mil. Becton Dickinson's overall GF Score™ is 70/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Becton Dickinson (XSWX:BDX), the current Other Current Payables is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Becton Dickinson (XSWX:BDX) Overvalued in 2026?

Based on GuruFocus' analysis, Becton Dickinson stock appears to be undervalued. The current stock price of CHF125.66 is trading 16.9% below its estimated GF Value™ of CHF151.22.

Key valuation signals for XSWX:BDX:

  • Other Current Payables: CHF0 Mil
  • GF Value™: CHF151.22 vs. price of CHF125.66 (16.9% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the XSWX:BDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Becton Dickinson Business Description

Address 1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
70GF Score

Get the complete analysis for XSWX:BDX

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF125.66
Price
CHF151.22
GF Value